Citigroup Inc Amneal Pharmaceuticals, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 152,451 shares of AMRX stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

152,451

Previous 72,383 110.62%

Holding current value

$1.2 Million

Previous $459,000 176.25%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$6.42 - $8.83 $514,036 - $707,000	80,068 Added 110.62%	152,451 $1.27 Million
Q2 2024 Aug 12, 2024	BUY	$5.36 - $7.11 $33,521 - $44,465	6,254 Added 9.46%	72,383 $459,000
Q1 2024 May 10, 2024	BUY	$5.24 - $6.34 $100,277 - $121,328	19,137 Added 40.72%	66,129 $400,000
Q4 2023 Feb 09, 2024	BUY	$3.36 - $6.21 $157,688 - $291,441	46,931 Added 76936.07%	46,992 $285,000
Q3 2023 Nov 09, 2023	SELL	$2.76 - $4.59 $100,027 - $166,350	-36,242 Reduced 99.83%	61 $0
Q2 2023 Aug 10, 2023	BUY	$1.33 - $3.1 $42,631 - $99,367	32,054 Added 754.39%	36,303 $112,000
Q1 2023 May 11, 2023	SELL	$1.27 - $2.7 $852 - $1,811	-671 Reduced 13.64%	4,249 $5,000
Q4 2022 Feb 09, 2023	SELL	$1.96 - $2.61 $1,824 - $2,429	-931 Reduced 15.91%	4,920 $9,000
Q3 2022 Nov 10, 2022	SELL	$2.02 - $3.62 $163,454 - $292,923	-80,918 Reduced 93.26%	5,851 $11,000
Q2 2022 Aug 10, 2022	BUY	$3.01 - $4.46 $220,238 - $326,333	73,169 Added 538.01%	86,769 $276,000
Q1 2022 May 12, 2022	SELL	$3.9 - $4.89 $68,569 - $85,975	-17,582 Reduced 56.39%	13,600 $57,000
Q4 2021 Feb 10, 2022	SELL	$3.95 - $5.85 $45,662 - $67,626	-11,560 Reduced 27.05%	31,182 $149,000
Q3 2021 Nov 10, 2021	BUY	$4.31 - $5.64 $184,218 - $241,064	42,742 New	42,742 $228,000

Others Institutions Holding AMRX

# of Institutions

184

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.19B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account